279 related articles for article (PubMed ID: 30577821)
1. The interactions of novel mononuclear platinum-based complexes with DNA.
Johnson BW; Burgess MW; Murray V; Aldrich-Wright JR; Temple MD
BMC Cancer; 2018 Dec; 18(1):1284. PubMed ID: 30577821
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes.
Johnson BW; Murray V; Temple MD
BMC Cancer; 2016 May; 16():333. PubMed ID: 27225032
[TBL] [Abstract][Full Text] [Related]
3. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
4. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
5. DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.
Novakova O; Kasparkova J; Malina J; Natile G; Brabec V
Nucleic Acids Res; 2003 Nov; 31(22):6450-60. PubMed ID: 14602903
[TBL] [Abstract][Full Text] [Related]
6. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
Kasparkova J; Novakova O; Farrell N; Brabec V
Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
[TBL] [Abstract][Full Text] [Related]
7. DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.
Brabec V; Kaspárková J; Vrána O; Nováková O; Cox JW; Qu Y; Farrell N
Biochemistry; 1999 May; 38(21):6781-90. PubMed ID: 10346899
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
9. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
Qu Y; Scarsdale NJ; Tran MC; Farrell NP
J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
[TBL] [Abstract][Full Text] [Related]
10. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
11. DNA interactions of antitumor cisplatin analogs containing enantiomeric amine ligands.
Malina J; Hofr C; Maresca L; Natile G; Brabec V
Biophys J; 2000 Apr; 78(4):2008-21. PubMed ID: 10733979
[TBL] [Abstract][Full Text] [Related]
12. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
13. Sequence specificity of DNA-DNA interstrand cross-link formation by cisplatin and dinuclear platinum complexes.
Zou Y; Van Houten B; Farrell N
Biochemistry; 1994 May; 33(18):5404-10. PubMed ID: 8180163
[TBL] [Abstract][Full Text] [Related]
14. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
[TBL] [Abstract][Full Text] [Related]
15. Interstrand cross-links of cisplatin induce striking distortions in DNA.
Malinge JM; Giraud-Panis MJ; Leng M
J Inorg Biochem; 1999 Oct; 77(1-2):23-9. PubMed ID: 10626349
[TBL] [Abstract][Full Text] [Related]
16. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
[TBL] [Abstract][Full Text] [Related]
17. Sequence specificity, conformation, and recognition by HMG1 protein of major DNA interstrand cross-links of antitumor dinuclear platinum complexes.
Kasparkova J; Farrell N; Brabec V
J Biol Chem; 2000 May; 275(21):15789-98. PubMed ID: 10747955
[TBL] [Abstract][Full Text] [Related]
18. A potent cytotoxic photoactivated platinum complex.
Mackay FS; Woods JA; Heringová P; Kaspárková J; Pizarro AM; Moggach SA; Parsons S; Brabec V; Sadler PJ
Proc Natl Acad Sci U S A; 2007 Dec; 104(52):20743-8. PubMed ID: 18093923
[TBL] [Abstract][Full Text] [Related]
19. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V
J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009
[TBL] [Abstract][Full Text] [Related]
20. Interaction of novel bis(platinum) complexes with DNA.
Roberts JD; Van Houten B; Qu Y; Farrell NP
Nucleic Acids Res; 1989 Dec; 17(23):9719-33. PubMed ID: 2690006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]